Pkh1_NP and_CC Pkh2_NP Differentially_NP Phosphorylate_NP and_CC Activate_NP Ypk1_NP and_CC Ykr2_NP and_CC Define_NP Protein_NP Kinase_NP Modules_NP Required_NP for_IN Maintenance_NP of_IN Cell_NP Wall_NP Integrity_NP Saccharomyces_NP cerevisiae_NNS Pkh1_NP and_CC Pkh2_NP are_VBP functionally_RB redundant_JJ homologs_NNS of_IN mammalian_JJ protein_NN kinase_NN ,_, phosphoinositide-dependent_JJ protein_NN kinase-1_NN ._SENT They_PP activate_VBP two_CD closely_RB related_VBN ,_, functionally_RB redundant_JJ enzymes_NNS ,_, Ypk1_NP and_CC Ykr2_NP (_( homologs_NNS of_IN mammalian_JJ protein_NN kinase_NN ,_, serum-_NN and_CC glucocorticoid-inducible_JJ protein_NN kinase_NN )_) ._SENT We_PP found_VBD that_IN Ypk1_NP has_VBZ a_DT more_RBR prominent_JJ role_NN than_IN Ykr2_NP in_IN mediating_VBG their_PP$ shared_JJ essential_JJ function_NN ._SENT Considerable_JJ evidence_NN demonstrated_VBD that_IN Pkh1_NP preferentially_RB activates_VBZ Ypk1_NP ,_, whereas_IN Pkh2_NP preferentially_RB activates_VBZ Ykr2_NP ._SENT Loss_NN of_IN Pkh1_NP (_( but_CC not_RB Pkh2_NP )_) reduced_VBD Ypk1_JJ activity_NN ;_: conversely_RB ,_, Pkh1_JJ overexpression_NN increased_VBN Ypk1_NP activity_NN more_RBR than_IN Pkh2_JJ overexpression_NN ._SENT Loss_NN of_IN Pkh2_NP reduced_VBD Ykr2_JJ activity_NN ;_: correspondingly_RB ,_, Pkh2_JJ overexpression_NN increased_VBN Ykr2_NP activity_NN more_RBR than_IN Pkh1_JJ overexpression_NN ._SENT When_WRB overexpressed_VBN ,_, a_DT catalytically_RB active_JJ C-terminal_JJ fragment_NN (_( kinase_NN domain_NN )_) of_IN Ypk1_NP was_VBD growth_NN inhibitory_JJ ;_: loss_NN of_IN Pkh1_NP (_( but_CC not_RB Pkh2_NP )_) alleviated_VBD toxicity_NN ._SENT Loss_NN of_IN Pkh2_NP (_( but_CC not_RB Pkh1_NP )_) exacerbated_VBD the_DT slow_JJ growth_NN phenotype_NN of_IN a_DT ypk1Delta_NN strain_NN ._SENT This_DT Pkh1-Ypk1_JJ and_CC Pkh2-Ykr2_JJ dichotomy_NN is_VBZ not_RB absolute_JJ because_IN all_DT double_JJ mutants_NNS (_( pkh1Delta_NP ypk1Delta_NP ,_, pkh2Delta_NP ypk1Delta_NP ,_, pkh1Delta_NN ykr2Delta_NN ,_, and_CC pkh2Delta_NN ykr2Delta_NNS )_) were_VBD viable_JJ ._SENT Compartmentation_NP contributes_VBZ to_TO selectivity_NN because_IN Pkh1_NP and_CC Ypk1_NP were_VBD located_VBN exclusively_RB in_IN the_DT cytosol_NN ,_, whereas_IN Pkh2_NP and_CC Ykr2_NP entered_VBD the_DT nucleus_NN ._SENT At_IN restrictive_JJ temperature_NN ,_, ypk1-1tsykr2Delta_NN cells_NNS lysed_VBD rapidly_RB ,_, but_CC not_RB in_IN medium_NN containing_VBG osmotic_JJ support_NN ._SENT Dosage_NN and_CC extragenic_JJ suppressors_NNS were_VBD selected_VBN ._SENT Overexpression_NN of_IN Exg1_NP (_( major_JJ exoglucanase_NN )_) ,_, or_CC loss_NN of_IN Kex2_NP (_( endoprotease_NN involved_VBN in_IN Exg1_JJ processing_NN )_) ,_, rescued_VBD growth_NN at_IN high_JJ temperature_NN ._SENT Viability_NN was_VBD also_RB maintained_VBN by_IN PKC1_JJ overexpression_NN or_CC an_DT activated_VBN allele_NN of_IN the_DT downstream_JJ protein_NN kinase_NN (_( BCK1-20_NP )_) ._SENT Conversely_RB ,_, absence_NN of_IN Mpk1_NP (_( distal_JJ mitogen-activated_JJ protein_NN kinase_NN of_IN the_DT PKC1_JJ pathway_NN )_) was_VBD lethal_JJ in_IN ypk1-1tsykr2Delta_NN cells_NNS ._SENT Thus_RB ,_, Pkh1-Ypk1_JJ and_CC Pkh2-Ykr2_JJ function_NN in_IN a_DT novel_JJ pathway_NN for_IN cell_NN wall_NN integrity_NN that_WDT acts_VBZ in_IN parallel_NN with_IN the_DT Pkc1-dependent_JJ pathway_NN ._SENT A_DT cascade_NN of_IN protein_NN kinases_NNS is_VBZ a_DT commonly_RB used_VBN mechanism_NN for_IN amplifying_VBG and_CC disseminating_VBG signals_NNS that_WDT control_VBP metabolism_NN ,_, growth_NN ,_, survival_NN ,_, and_CC differentiation_NN in_IN eukaryotic_JJ cells_NNS ._SENT In_IN animal_JJ cells_NNS ,_, recruitment_NN of_IN phosphatidylinositol_NN 3-kinase_NN by_IN growth_NN factor_NN receptors_NNS generates_VBZ 3-phosphoinositides_NNS ,_, which_WDT stimulate_VBP 3-phosphoinositide-dependent_JJ protein_NN kinase-1_NN (_( PDK1_NP )_) (_( for_IN review_NN ,_, see_VBP ;_: )_) ._SENT Activated_VBN PDK1_JJ phosphorylates_NNS and_CC activates_VBZ multiple_JJ downstream_JJ targets_NNS ,_, including_VBG protein_NN kinase_NN B/c-Akt_NP ,_, p70_JJ S6_NP kinase_NN ,_, protein_NN kinase_NN C_NP (_( PKC_NP )_) isoforms_NNS ,_, and_CC serum-_NN and_CC glucocorticoid-inducible_JJ protein_NN kinase_NN (_( SGK_NP )_) isoforms_NNS ,_, thereby_RB eliciting_VBG physiological_JJ responses_NNS ._SENT We_PP have_VBP demonstrated_VBN previously_RB that_IN ,_, in_IN budding_VBG yeast_NN (_( Saccharomyces_NP cerevisiae_NNS )_) ,_, Pkh1_NP and_CC Pkh2_NP are_VBP the_DT homologs_NNS and_CC functional_JJ equivalents_NNS of_IN mammalian_JJ PDK1_NP ._SENT Pkh1_JJ and_CC Pkh2_JJ share_NN an_DT essential_JJ function_NN because_IN pkh1Delta_NN and_CC pkh2Delta_NN single_JJ mutants_NNS are_VBP viable_JJ ,_, whereas_IN a_DT pkh1Delta_NN pkh2Delta_NN double_JJ mutant_NN is_VBZ inviable_JJ ._SENT Expression_NN of_IN human_JJ PDK1_NP rescues_VBZ the_DT lethality_NN of_IN a_DT pkh1Delta_NN pkh2Delta_NN strain_NN ._SENT The_DT PDK1_JJ enzymes_NNS from_IN Caenorhabditis_NP elegans_NNS ,_, Drosophila_NP melanogaster_NN ,_, and_CC Homo_NP sapiens_JJ all_RB possess_VBP a_DT C-terminal_JJ pleckstrin_NN homology_NN (_( PH_NN )_) domain_NN that_WDT binds_VBZ phosphatidylinositol_NN (PtdIns)(3,4,5)P3_NN and_CC PtdIns(3,4)P2_NN ._SENT However_RB ,_, S._NP cerevisiae_NNS does_VBZ not_RB produce_VB PtdIns(3,4,5)P3_NP or_CC PtdIns(3,4)P2_NP ._SENT Moreover_RB ,_, Pkh1_NP and_CC Pkh2_NP lack_VBP discernible_JJ PH_NN domains_NNS ,_, and_CC PDK1_JJ lacking_VBG its_PP$ PH_NN domain_NN was_VBD sufficient_JJ to_TO rescue_VB the_DT growth_NN of_IN pkh1Delta_NN pkh2Delta_NN cells_NNS ,_, suggesting_VBG that_IN the_DT activity_NN of_IN Pkh1_NP and_CC Pkh2_NP in_IN yeast_NN does_VBZ not_RB depend_VB on_IN phosphoinositides_NNS ._SENT It_PP was_VBD shown_VBN subsequently_RB that_DT sphingosine_NN (_( 4-dehydro-sphinganine_JJ )_) can_MD also_RB stimulate_VB mammalian_JJ PDK1_JJ autophosphorylation_NN and_CC increase_VB its_PP$ ability_NN to_TO phosphorylate_VB in_IN vitro_NN known_VBN PDK1_JJ substrates_NNS ,_, such_JJ as_IN c-Akt_NP and_CC PKCbeta_NP ._SENT Correspondingly_RB ,_, it_PP has_VBZ been_VBN reported_VBN recently_RB that_IN Pkh1_NP and_CC Pkh2_NP can_MD be_VB activated_VBN in_IN vitro_NN by_IN nanomolar_JJ concentrations_NNS of_IN the_DT major_JJ sphingoid_JJ base_NN in_IN yeast_NN ,_, phytosphingosine_NN (_( 4-hydroxy-sphinganine_JJ )_) ._SENT Moreover_RB ,_, endocytosis_NN in_IN yeast_NN seems_VBZ to_TO require_VB sphingoid_JJ base_NN synthesis_NN and_CC overexpression_NN of_IN Pkh1_NP or_CC Pkh2_NP can_MD suppress_VB this_DT requirement_NN ,_, suggesting_VBG that_IN sphingoid_JJ bases_NNS activate_VBP a_DT signaling_VBG pathway_NN involving_VBG Pkh1_NP and_CC Pkh2_NP ._SENT Mammalian_JJ PDK1_NP activates_VBZ its_PP$ downstream_JJ targets_NNS by_IN phosphorylating_VBG a_DT Thr_NP residue_NN (_( starred_JJ )_) in_IN a_DT sequence_NN motif_NN ,_, Thr*-Phe-Cys-Gly-Thr-X-Glu-Tyr_NP (_( where_WRB X_NP represents_VBZ any_DT amino_NN acid_NN )_) ,_, that_WDT lies_VBZ within_IN the_DT "_`` activation_NN loop_NN "_'' of_IN their_PP$ catalytic_JJ domains_NNS and_CC is_VBZ unique_JJ to_TO and_CC conserved_VBN in_IN all_DT known_VBN PDK1_JJ substrates_NNS ._SENT Full_JJ activation_NN of_IN c-Akt/PKB_NP and_CC other_JJ PDK1_JJ targets_NNS also_RB seems_VBZ to_TO require_VB phosphorylation_NN at_IN a_DT second_JJ site_NN (_( starred_JJ )_) situated_VBN in_IN a_DT hydrophobic_JJ motif_NN ,_, Phe-X-X-Ar-Ser*/Thr*-Ar_NP (_( where_WRB Ar_NP represents_VBZ an_DT aromatic_JJ residue_NN )_) ,_, that_WDT is_VBZ located_VBN near_IN the_DT C_NP terminus_NN of_IN each_DT of_IN these_DT enzymes_NNS ._SENT In_IN S._NP cerevisiae_NNS ,_, four_CD previously_RB characterized_VBN protein_NN kinases_NNS possess_VBP both_DT of_IN these_DT motifs_NNS ,_, suggesting_VBG that_IN they_PP are_VBP physiological_JJ substrates_NNS of_IN Pkh1_NP and/or_CC Pkh2_NP ._SENT These_DT four_CD protein_NN kinases_NNS are_VBP the_DT products_NNS of_IN the_DT following_VBG genes_NNS :_: YPK1_NP ,_, YKR2/YPK2_NP ,_, PKC1_NP ,_, and_CC SCH9_NP ._SENT Studies_NNS from_IN this_DT laboratory_NN have_VBP demonstrated_VBN that_IN Ypk1_NP is_VBZ a_DT direct_JJ substrate_NN of_IN Pkh1_NP and_CC that_IN Ykr2_NP is_VBZ phosphorylated_JJ by_IN Pkh2_NP ._SENT Similarly_RB ,_, it_PP has_VBZ been_VBN shown_VBN that_IN Pkc1_NP can_MD also_RB be_VB phosphorylated_JJ by_IN Pkh1_NP and_CC Pkh2_NP ._SENT Reduced_VBN Pkc1_JJ activity_NN was_VBD observed_VBN in_IN a_DT pkh1-1ts_NNS pkh2Delta_NN strain_NN ,_, and_CC the_DT temperature_NN sensitivity_NN of_IN this_DT strain_NN was_VBD partially_RB suppressed_VBN by_IN a_DT dominant_JJ PKC1(R398P)_NP allele_NN ,_, suggesting_VBG that_IN Pkh1_NP and_CC Pkh2_NP are_VBP required_VBN for_IN Pkc1_JJ function_NN in_IN vivo_RB ._SENT The_DT catalytic_JJ domains_NNS of_IN Ypk1_NP and_CC Ykr2_NP are_VBP 88_CD %_NN identical_JJ and_CC these_DT proteins_NNS also_RB share_VBP extensive_JJ homology_NN across_IN their_PP$ N-_NN and_CC C-terminal_JJ extensions_NNS ._SENT Moreover_RB ,_, the_DT catalytic_JJ domains_NNS of_IN Ypk1_NP and_CC Ykr2_NP closely_RB resemble_VBP (_( 55_CD %_NN identity_NN )_) that_IN of_IN mammalian_JJ SGK_NP ._SENT Indeed_RB ,_, cells_NNS lacking_VBG Ypk1_NP or_CC Ykr2_NP are_VBP viable_JJ ,_, whereas_IN cells_NNS lacking_VBG both_DT Ypk1_NP and_CC Ykr2_NP are_VBP inviable_JJ ,_, and_CC expression_NN of_IN mammalian_JJ SGK_NP rescues_VBZ this_DT inviability_NN ._SENT Furthermore_RB ,_, both_CC purified_VBD PDK1_JJ and_CC purified_VBN Pkh1_JJ phosphorylate_NN the_DT same_JJ residue_NN (_( Thr504_NP )_) in_IN the_DT consensus_NN motif_NN in_IN purified_VBN Ypk1_NP ,_, and_CC Ypk1_JJ phosphorylation_NN is_VBZ significantly_RB diminished_VBN in_IN vivo_JJ in_IN cells_NNS lacking_VBG Pkh1_JJ ._SENT Thus_RB ,_, just_RB as_IN SGK_NP is_VBZ a_DT downstream_JJ target_NN of_IN PDK1_NP in_IN animal_JJ cells_NNS ,_, Ypk1_NP and_CC Ykr2_NP seem_VBP to_TO act_VB downstream_JJ of_IN Pkh1_NP and_CC Pkh2_NP in_IN yeast_NN ._SENT Moreover_RB ,_, lipid-derived_JJ signals_NNS are_VBP required_VBN as_IN upstream_JJ activators_NNS in_IN both_DT pathways_NNS ,_, 3-phosphoinositides_NNS and_CC sphingosine_NN in_IN the_DT case_NN of_IN PDK1_JJ and_CC closely_RB related_VBN sphingoid_JJ bases_NNS in_IN the_DT case_NN of_IN Pkh1_NP and_CC Pkh2_NP ._SENT Consistent_JJ with_IN this_DT view_NN ,_, overexpression_NN of_IN Ypk1_NP confers_VBZ resistance_NN to_TO myriocin_NP (_( ISP-1_NP )_) ,_, an_DT antibiotic_NN that_WDT specifically_RB inhibits_VBZ serine_NN C-palmitoyltransferase_NP (_( product_NN of_IN the_DT LCB1_NP gene_NN )_) ,_, which_WDT is_VBZ the_DT enzyme_NN responsible_JJ for_IN sphinganine_JJ biosynthesis_NN ._SENT Herein_RB ,_, we_PP describe_VBP experiments_NNS that_WDT address_VBP the_DT genetic_JJ and_CC biochemical_JJ interrelationships_NNS between_IN Pkh1_NP and_CC Pkh2_NP and_CC Ypk1_NP and_CC Ykr2_NP ,_, which_WDT we_PP undertook_VBD to_TO try_VB to_TO understand_VB the_DT reason_NN for_IN the_DT redundancies_NNS within_IN these_DT protein_NN kinase_NN cascades_NNS ._SENT To_TO provide_VB further_JJR insight_NN ,_, we_PP also_RB investigated_VBD the_DT subcellular_JJ localization_NN of_IN all_DT four_CD proteins_NNS ._SENT Finally_RB ,_, as_IN two_CD independent_JJ approaches_NNS for_IN discerning_VBG the_DT physiological_JJ function_NN of_IN the_DT Ypk1_NP and_CC Ykr2_NP enzymes_NNS ,_, we_PP selected_VBD for_IN dosage_NN suppressors_NNS and_CC also_RB for_IN chromosomal_JJ mutations_NNS that_WDT suppress_VBP the_DT lysis_NN phenotype_NN of_IN ypk1-1ts_JJ ykr2Delta_NN cells_NNS ._SENT Strains_NNS and_CC Growth_NP Conditions_NPS |_SYM Yeast_NP strains_NNS used_VBN in_IN this_DT study_NN are_VBP listed_VBN in_IN Table_NP ._SENT Standard_JJ rich_JJ (_( YP_NP )_) and_CC defined_VBD minimal_JJ (_( SC_NP )_) media_NNS ,_, containing_VBG either_RB 2_CD %_NN glucose_NN (_( Glc_NP )_) ,_, 2_CD %_NN raffinose_NN (_( Raf_NP )_) ,_, or_CC 2_CD %_NN galactose_NN (_( Gal_NP )_) as_IN the_DT carbon_NN source_NN and_CC supplemented_VBN with_IN appropriate_JJ nutrients_NNS to_TO maintain_VB selection_NN for_IN plasmids_NNS ,_, were_VBD used_VBN for_IN yeast_NN cultivation_NN ._SENT For_IN gene_NN expression_NN from_IN the_DT galactose-inducible_JJ GAL1_JJ promoter_NN in_IN liquid_JJ media_NNS ,_, cells_NNS were_VBD pregrown_JJ to_TO mid-exponential_JJ phase_NN in_IN SC_NP containing_VBG 2_CD %_NN raffinose-0.2_JJ %_NN sucrose_NN (_( Raf/Suc_NP )_) and_CC then_RB Gal_NP was_VBD added_VBN to_TO a_DT final_JJ concentration_NN of_IN 2_CD %_NN and_CC incubation_NN continued_VBN for_IN 2_CD h._NN In_IN experiments_NNS involving_VBG growth_NN on_IN solid_JJ medium_NN containing_VBG 5-fluoroorotic_JJ acid_NN ,_, 5-fluoroorotic_JJ acid_NN was_VBD used_VBN at_IN a_DT concentration_NN of_IN 0.5_CD mg/ml_NN ._SENT Cells_NNS were_VBD grown_VBN routinely_RB at_IN 30C_JJ ,_, except_IN for_IN strains_NNS carrying_VBG temperature-sensitive_NN mutations_NNS ,_, which_WDT were_VBD propagated_VBN at_IN their_PP$ permissive_JJ temperature_NN (_( 26C_JJ )_) ._SENT Table_NP 1_CD |_SYM S._NP cerevisiae_NNS strains_NNS used_VBN in_IN this_DT study_NN Recombinant_NP DNA_NP Methods_NP |_SYM Escherichia_NP coli_NNS strain_VBP DH5alpha_NP was_VBD used_VBN for_IN the_DT construction_NN and_CC propagation_NN of_IN plasmids_NNS ._SENT Conventional_JJ recombinant_JJ DNA_NN methods_NNS were_VBD used_VBN for_IN the_DT construction_NN of_IN plasmids_NNS ._SENT The_DT sequences_NNS of_IN constructs_NNS that_WDT contained_VBD DNA_NN fragments_NNS amplified_VBN by_IN polymerase_NN chain_NN reaction_NN (_( PCR_NP )_) were_VBD verified_VBN by_IN the_DT dideoxy_JJ chain_NN termination-sequencing_NN method_NN ._SENT Native_JJ and_CC Turbo_NP Pfu_NP polymerases_NNS (_( Stratagene_NP ,_, La_NP Jolla_NP ,_, CA_NP )_) were_VBD used_VBN for_IN PCR_NP ,_, unless_IN noted_VBD otherwise_RB ._SENT Plasmids_NN |_SYM Plasmids_NNS pYPK1_JJ ,_, pYKR2_JJ ,_, pGAL-YPK1_JJ ,_, pGAL-YKR2_JJ (_( pAM1_JJ )_) ,_, pGAL-Ypk1-Myc_NN (_( pAM54_NN )_) ,_, pADH-YPK1_JJ ,_, pRS316-YKR2_JJ (_( pAM12_JJ )_) ,_, pGAL-PKH1_JJ (_( pAM73_NN )_) ,_, and_CC pGAL-PKH2_JJ (_( pAM79_NN )_) have_VBP been_VBN described_VBN previously_RB ._SENT To_TO create_VB plasmid_NP pADH-YKR2_NP (_( pAM4_NN )_) ,_, which_WDT constitutively_RB overexpresses_VBZ YKR2_NP from_IN the_DT ADH1_JJ promoter_NN ,_, a_DT 2.4-kb_JJ XhoI_NP (blunt)-SalI_NN fragment_NN containing_VBG the_DT entire_JJ YKR2_NP gene_NN was_VBD excised_VBN from_IN pYKR2_NN ,_, gel_NN purified_VBD ,_, and_CC inserted_VBN into_IN vector_NN pAD4_NN M_NN that_WDT had_VBD been_VBN linearized_VBN with_IN SmaI/SalI_NP ._SENT To_TO generate_VB a_DT version_NN of_IN Ykr2_NP tagged_VBN at_IN its_PP$ C-terminal_JJ end_NN with_IN the_DT c-Myc_NP epitope_NN ,_, a_DT PCR-based_JJ method_NN for_IN precise_JJ gene_NN fusion_NN was_VBD performed_VBN using_VBG the_DT YKR2_NP sequence_NN cloned_VBN in_IN pUC18_NN as_IN one_CD template_NN (_( pYKR2_NN )_) ,_, and_CC as_IN the_DT other_JJ template_NN ,_, pOGFP_NP (_( E._NP Swartzman_NP ,_, this_DT laboratory_NN )_) ,_, which_WDT contains_VBZ a_DT sequence_NN encoding_VBG the_DT 16-residue_JJ version_NN of_IN the_DT c-Myc_NP epitope_NN followed_VBD by_IN a_DT (His)6_JJ tag_NN cloned_VBN in_IN pBluescript_NN (_( Stratagene_NP )_) ;_: with_IN three_CD appropriate_JJ synthetic_JJ oligonucleotide_NN primers_NNS :_: T3_NP (_( Stratagene_NP )_) ;_: 5'-GGA_NP CAT_NP ATT_NP GCA_NP CTG_NP TGT_NP G-3_NP '_'' (_( RMN5_NP )_) ,_, corresponding_VBG to_TO sequences_NNS in_IN YKR2_NP overlapping_VBG a_DT DraIII_NP site_NN near_IN the_DT C_NP terminus_NN ;_: and_CC a_DT "_`` joiner_NN "_'' primer_NN ,_, 5'-TTC_NP AGA_NP AAT_NP CAA_NP CTT_NP TTG_NP TTC_NP ACT_NP AAT_NP GCT_NP TCT_NP CCC_NP CTG-3_NP '_'' (_( RMC_NP )_) ,_, corresponding_VBG to_TO the_DT 3_CD '_POS end_NN of_IN the_DT YKR2_JJ coding_VBG sequence_NN and_CC the_DT first_JJ several_JJ residues_NNS of_IN the_DT c-Myc_NP epitope_NN ._SENT An_DT similar1.6-kb_NP DraIII/KpnI_NP fragment_NN of_IN the_DT resulting_JJ PCR_NP product_NN was_VBD used_VBN to_TO replace_VB the_DT corresponding_JJ segment_NN in_IN pYKR2_NN ,_, yielding_VBG pYkr2-Myc_NN (_( pAM24_NN )_) ._SENT An_DT similar3-kb_NP NcoI/HindIII_NP fragment_NN from_IN pYkr2-Myc_NN was_VBD gel_NN purified_VBN and_CC used_VBN to_TO replace_VB the_DT corresponding_JJ similar2.2-kb_NN NcoI/HindIII_NP segment_NN in_IN pGAL-YKR2_NN to_TO create_VB a_DT 2-mum_JJ DNA-containing_NP ,_, LEU2-marked_NP plasmid_NP ,_, pGAL-Ykr2-Myc_NN (_( pAM59_NN )_) ,_, that_WDT overexpresses_VBZ Ykr2-Myc_NP upon_IN galactose_NN induction_NN ._SENT To_TO generate_VB a_DT catalytically_RB inactive_JJ (_( "_`` kinase-dead_NN "_'' )_) version_NN of_IN Ypk1_NP ,_, a_DT PCR-based_JJ method_NN for_IN site-directed_JJ mutagenesis_NN was_VBD performed_VBN using_VBG pYPK1_JJ as_IN the_DT template_NN and_CC three_CD appropriate_JJ synthetic_JJ oligonucleotide_NN primers_NNS :_: 5'-CTT_NP GAA_NP CAC_NP AGT_NP AAG_NP TAA_NP CGG-3_NP '_'' (_( PKC2_NP )_) ,_, corresponding_VBG to_TO the_DT flanking_VBG genomic_JJ sequence_NN commencing_VBG 68-base_JJ pairs_NNS downstream_JJ of_IN the_DT stop_NN codon_NN ;_: 5'-CAC_NP AAA_NP AAG_NP TAT_NP ACG_NP CCT_NP TGG_NP CGG_NP CAA_NP TCA_NP G-3_NP '_'' (_( PKD_NP )_) ,_, where_WRB the_DT underlined_VBN nucleotide_NN is_VBZ a_DT silent_JJ mutation_NN to_TO introduce_VB a_DT BglI_NP site_NN ,_, and_CC the_DT bold_JJ nucleotides_NNS correspond_VBP to_TO an_DT introduced_VBN alanine_NN codon_NN (_( GCG_NP )_) in_IN place_NN of_IN the_DT native_JJ lysine_NN codon_NN (_( AAG_NP )_) ;_: and_CC 5'-GTC_NP CAT_NP CGA_NP TGA_NP TTT_NP CGA_NP TC-3_NP '_'' (_( Pseq2_NP )_) ,_, corresponding_VBG to_TO the_DT coding_VBG strand_NN of_IN YPK1_NP starting_VBG at_IN nucleotide_NN position_NN 1024_CD ._SENT The_DT resulting_VBG similar1.1-kb_NP PCR_NP product_NN was_VBD digested_VBN with_IN ClaI_NP and_CC NcoI_NP ,_, and_CC the_DT resulting_VBG similar850-base_JJ pair_NN fragment_NN was_VBD used_VBN to_TO replace_VB the_DT corresponding_JJ segment_NN in_IN pYPK1_NN ,_, yielding_VBG pYPK1(K376A-KD)_NN (_( pAM46_NN )_) ._SENT Conversion_NN of_IN the_DT Lys_NP residue_NN at_IN the_DT equivalent_JJ position_NN in_IN all_DT other_JJ protein_NN kinases_NNS examined_VBD to_TO date_NN eliminates_VBZ their_PP$ catalytic_JJ activity_NN ._SENT To_TO generate_VB a_DT catalytically_RB inactive_JJ (_( kinase-dead_NN )_) version_NN of_IN Ykr2_NP ,_, a_DT similar_JJ PCR-based_JJ approach_NN for_IN site-directed_JJ mutagenesis_NN was_VBD performed_VBN using_VBG pYKR2_NN as_IN the_DT template_NN ,_, and_CC three_CD appropriate_JJ synthetic_JJ oligonucleotide_NN primers_NNS :_: 5'-AGT_NP ATA_NP GCC_NP CTG_NP CCC_NP CAA_NP C-3_NP '_'' (_( Rseq2_NP )_) ,_, corresponding_VBG to_TO the_DT noncoding_JJ strand_NN of_IN YKR2_NP commencing_VBG at_IN nucleotide_NN position_NN 1544_CD ;_: 5'-CCC_NP AAA_NP AGA_NP TTT_NP ACG_NP CCT_NP TGG_NP CGG_NP CTC_NP TGA_NP G-3_NP '_'' (_( RKD_NP )_) ,_, where_WRB the_DT underlined_VBN nucleotide_NN is_VBZ a_DT silent_JJ mutation_NN to_TO introduce_VB a_DT BglI_NP site_NN ,_, and_CC the_DT bold_JJ nucleotides_NNS correspond_VBP to_TO an_DT introduced_VBN alanine_NN codon_NN (_( GCG_NP )_) in_IN place_NN of_IN the_DT native_JJ lysine_NN codon_NN (_( AAG_NP )_) ;_: and_CC 5'-CGT_NP GGG_NP GTA_NP ATG_NP GCC_NP TG-3_NP '_'' (_( Rseq3_NP )_) ,_, corresponding_VBG to_TO the_DT coding_VBG strand_NN of_IN YKR2_NP starting_VBG at_IN nucleotide_NN position_NN 66_CD ._SENT The_DT resulting_VBG similar1.4-kb_NP PCR_NP product_NN was_VBD digested_VBN with_IN NcoI_NP and_CC DraIII_NP and_CC used_VBN to_TO replace_VB the_DT corresponding_JJ segment_NN in_IN pYKR2_NN ,_, yielding_VBG pYKR2(K373A-KD)_NN (_( pAM47_JJ )_) ._SENT Plasmid_NP pYPK1(K376A-KD)_NP was_VBD digested_VBN with_IN AlwnI_NP ,_, converted_VBN to_TO flush_VB ends_NNS by_IN treatment_NN with_IN T4_NP polymerase_NN (_( NEB_NP )_) and_CC all_DT four_CD dNTPs_NNS then_RB digested_VBN with_IN SalI_NP ._SENT The_DT resulting_VBG 3.3-kb_JJ YPK1(K376A-KD)_NP --_: containing_VBG fragment_NN was_VBD gel_NN purified_VBN and_CC ligated_VBN into_IN YEp351GAL_NP that_WDT had_VBD been_VBN linearized_VBN by_IN digestion_NN with_IN XbaI_NP ,_, converted_VBN to_TO flush_VB ends_NNS by_IN incubation_NN with_IN T4_NP polymerase_NN and_CC all_DT four_CD dNTPs_NNS ,_, and_CC then_RB digested_VBN with_IN SalI_NP ._SENT The_DT resulting_VBG plasmid_NN ,_, pGAL-YPK1(K376A-KD)_JJ (_( pAM48_NN )_) ,_, expresses_VBZ a_DT catalytically_RB inactive_JJ allele_NN [_SYM Ypk1-(K376A-KD)_NP ]_SYM from_IN a_DT 2-mum_JJ DNA-containing_NP ,_, LEU2-marked_NP plasmid_NP under_IN control_NN of_IN the_DT GAL1_JJ promoter_NN ._SENT An_DT similar1.2-kb_NP NcoI/SalI_NP fragment_NN from_IN pYpk1-Myc_NN was_VBD gel_NN purified_VBN and_CC used_VBN to_TO replace_VB the_DT corresponding_JJ NcoI/SalI_NP segment_NN in_IN pGAL-YPK1(K376A-KD)_NN to_TO create_VB pGAL-YPK1(K376A-KD)-Myc_NP (_( pAM49_NN )_) ._SENT An_DT similar2.4-kb_NP XhoI-HindIII_NP fragment_NN containing_VBG the_DT entire_JJ YKR2(K373A-KD)_NP allele_NN was_VBD excised_VBN from_IN pYKR2(K373A-KD)_NN ,_, gel_NN purified_VBD ,_, and_CC inserted_VBN into_IN YEp351GAL_NP that_WDT had_VBD been_VBN linearized_VBN with_IN SalI_NP and_CC HindIII_NP ,_, to_TO create_VB a_DT 2-mum_JJ DNA-containing_NP ,_, LEU2-marked_NP plasmid_NP ,_, pGAL-YKR2(K373A-KD)_JJ (_( pAM50_NN )_) ,_, that_WDT overexpresses_VBZ catalytically_RB inactive_JJ Ykr2_NN upon_IN galactose_NN induction_NN ._SENT Galactose-inducible_JJ expression_NN vectors_NNS that_WDT are_VBP URA3_JJ based_VBN were_VBD constructed_VBN as_RB follows_VBZ ._SENT An_DT similar3.3-kb_NP BamHI/HindIII_NP fragment_NN carrying_VBG YPK1_NP was_VBD excised_VBN from_IN pGAL-YPK1_NN ,_, gel_NN purified_VBD ,_, and_CC ligated_VBD into_IN YEp352GAL_NP ,_, which_WDT had_VBD been_VBN linearized_VBN with_IN BamHI/HindIII_NP ,_, yielding_VBG YEp352GAL-YPK1_NP (_( pAM75_NN )_) ._SENT An_DT similar3.8-kb_NP BamHI/HindIII_NP fragment_NN from_IN pGAL-Ypk1-Myc_NN was_VBD gel_NN purified_VBN and_CC ligated_VBN into_IN YEp352GAL_NP that_WDT had_VBD been_VBN linearized_VBN with_IN BamHI/HindIII_NP ,_, yielding_VBG YEp352GAL-Ypk1-Myc_NP (_( pAM76_NN )_) ._SENT An_DT similar2.2-kb_NP BamHI/HindIII_NP fragment_NN from_IN p2GAL-YKR2_NN was_VBD gel_NN purified_VBN and_CC ligated_VBN into_IN YEp352GAL_NP ,_, which_WDT had_VBD been_VBN linearized_VBN with_IN BamHI/HindIII_NP ,_, yielding_VBG YEp352GAL-YKR2_NP (_( pAM77_JJ )_) ._SENT An_DT similar3.0-kb_NP BamHI/HindIII_NP fragment_NN from_IN p2GAL-Ykr2-Myc_NN was_VBD gel_NN purified_VBN and_CC ligated_VBN into_IN YEp352GAL_NP ,_, which_WDT had_VBD been_VBN linearized_VBN with_IN BamHI/HindIII_NP ,_, yielding_VBG YEp352GAL-Ykr2-Myc_NP (_( pAM78_NN )_) ._SENT To_TO generate_VB an_DT amino-terminal_JJ truncation_NN of_IN Ypk1_NP ,_, the_DT following_VBG two-step_JJ approach_NN was_VBD taken_VBN ._SENT First_RB ,_, an_DT similar1.1-kb_NN fragment_NN corresponding_JJ to_TO the_DT last_JJ 344_CD amino_NN acids_NNS of_IN Ypk1_NP was_VBD amplified_VBN by_IN PCR_NP from_IN pYPK1_NN with_IN the_DT following_VBG oligonucleotides_NNS :_: 5'-GGC_NP GGA_NP TCCATG_NP TCC_NP AGA_NP AAT_NP AAA_NP CCT_NP TTG_NP TCC-3_NP '_'' (_( PCT_NP )_) ,_, corresponding_VBG to_TO sequences_NNS in_IN the_DT middle_NN of_IN the_DT YPK1_JJ coding_VBG sequence_NN ,_, just_RB upstream_RB of_IN the_DT beginning_NN of_IN the_DT catalytic_JJ domain_NN ,_, where_WRB the_DT underlined_VBN nucleotides_NNS correspond_VBP to_TO an_DT introduced_VBN BamHI_NP restriction_NN site_NN ,_, and_CC the_DT bold_JJ nucleotides_NNS represent_VBP an_DT introduced_VBN start_NN codon_NN (_( ATG_NP )_) ;_: and_CC 5'-CTT_NP GAA_NP CAC_NP AGT_NP AAG_NP TAA_NP CGG-3_NP '_'' (_( PKC2_NP )_) ,_, corresponding_VBG to_TO the_DT flanking_VBG genomic_JJ sequence_NN commencing_VBG 68-base_JJ pairs_NNS downstream_JJ of_IN the_DT stop_NN codon_NN ._SENT The_DT resulting_JJ PCR_NP product_NN was_VBD digested_VBN with_IN BamHI_NP and_CC NcoI_NP ,_, gel_NN purified_VBD ,_, and_CC used_VBD to_TO replace_VB an_DT similar2.6-kb_JJ BamHI/NcoI_NP fragment_NN in_IN pRS315-YPK1(B/H_NN )_) ._SENT The_DT resulting_VBG CEN-containing_NP ,_, LEU2-marked_NP plasmid_NP encodes_VBZ an_DT amino-terminal_JJ truncation_NN of_IN Ypk1_NP ,_, which_WDT contains_VBZ only_RB the_DT catalytic_JJ domain_NN ,_, but_CC essentially_RB no_DT promoter_NN sequence_NN ,_, and_CC is_VBZ called_VBN pRS315-YPK1-DeltaN_NN (_( pAM55_NN )_) ._SENT An_DT similar1.2-kb_NP NcoI/SalI_NP fragment_NN from_IN pRS315-Ypk1-myc_NN was_VBD gel_NN purified_VBN and_CC used_VBN to_TO replace_VB the_DT corresponding_JJ NcoI/SalI_NP segment_NN in_IN pRS315-YPK1-DeltaN_NN to_TO create_VB a_DT CEN-containing_NP ,_, LEU2-marked_NP plasmid_NP ,_, pRS315-Ypk1-DeltaN-myc_NN (_( pAM56_NN )_) ,_, that_WDT encodes_VBZ a_DT myc-tagged_JJ version_NN of_IN the_DT Ypk1_JJ catalytic_JJ domain_NN ._SENT To_TO insert_VB a_DT promoter_NN ,_, an_DT similar2.3-kb_NP BamHI/SalI_NP fragment_NN from_IN pRS315-YPK1-DeltaN_NN was_VBD gel_NN purified_VBN and_CC inserted_VBN into_IN YEp351GAL_NP that_WDT had_VBD been_VBN linearized_VBN with_IN BamHI/SalI_NP to_TO create_VB a_DT 2-mum_JJ DeltaNA-containing_NP ,_, LEU2-marked_NP plasmid_NP ,_, pGAL-YPK1-DeltaN_NP (_( pAM99_NN )_) ,_, that_WDT overexpresses_VBZ the_DT amino-terminal_JJ truncation_NN of_IN Ypk1_NP upon_IN galactose_NN induction_NN ._SENT Likewise_RB ,_, an_DT similar2.0-kb_NP BamHI/SalI_NP fragment_NN from_IN pRS315-Ypk1-DeltaN-Myc_NN was_VBD gel_NN purified_VBN and_CC inserted_VBN into_IN YEp351GAL_NP that_WDT had_VBD been_VBN linearized_VBN with_IN BamHI/SalI_NP to_TO create_VB a_DT 2-mum_JJ DeltaNA-containing_NP ,_, LEU2-marked_NP plasmid_NP ,_, pGAL-Ypk1-DeltaN-Myc_NN (_( pAM100_NN )_) ,_, that_WDT overexpresses_VBZ a_DT myc-tagged_JJ version_NN of_IN the_DT amino-terminal_JJ truncation_NN of_IN Ypk1_NP upon_IN galactose_NN induction_NN ._SENT To_TO move_VB these_DT truncated_JJ Ypk1_JJ derivatives_NNS into_IN URA3-marked_JJ plasmids_NNS ,_, an_DT similar2.3-kb_NP BamHI/SalI_NP fragment_NN from_IN pGAL-YPK1-DeltaN_NN was_VBD gel_NN purified_VBN and_CC inserted_VBN into_IN YEp352GAL_NP that_WDT had_VBD been_VBN linearized_VBN with_IN BamHI/SalI_NP to_TO create_VB a_DT 2-mum_JJ DNA-containing_NP ,_, URA3-marked_NP plasmid_NP ,_, YEp352GAL-YPK1-DeltaN_NP (_( pAM101_JJ )_) ,_, that_WDT overexpresses_VBZ the_DT amino-terminal_JJ truncation_NN of_IN Ypk1_NP upon_IN galactose_NN induction_NN ._SENT Similarly_RB ,_, an_DT similar2.0-kb_NP BamHI/SalI_NP fragment_NN from_IN pGAL-Ypk1-DeltaN-Myc_NN was_VBD gel_NN purified_VBN and_CC inserted_VBN into_IN YEp352GAL_NP that_WDT had_VBD been_VBN linearized_VBN with_IN BamHI/SalI_NP to_TO create_VB a_DT 2-mum_JJ DNA-containing_NP ,_, URA3-marked_NP plasmid_NP ,_, YEp352GAL-Ypk1-DeltaN-myc_NP (_( pAM102_NN )_) ,_, that_WDT overexpresses_VBZ a_DT myc-tagged_JJ version_NN of_IN the_DT amino-terminal_JJ truncation_NN of_IN Ypk1_NP upon_IN galactose_NN induction_NN ._SENT To_TO generate_VB a_DT catalytically_RB inactive_JJ derivative_NN of_IN the_DT Ypk1-DeltaN_NP allele_NN ,_, a_DT 2.3-kb_JJ ClaI/HindIII_NP fragment_NN from_IN pGAL-YPK1-KD_NNS ,_, encoding_VBG the_DT carboxy_JJ terminus_NN (_( containing_VBG the_DT K376A_NP kinase-dead_NN mutation_NN of_IN Ypk1_NP )_) was_VBD gel_NN purified_VBN and_CC used_VBN to_TO replace_VB the_DT corresponding_JJ segment_NN in_IN YEp352GAL-Ypk1-DeltaN-Myc_NP ._SENT The_DT resulting_VBG plasmid_NN ,_, YEp352GAL-Ypk1-DeltaN-KD_NP (_( pFR30_NN )_) ,_, overexpresses_VBZ a_DT catalytically_RB inactive_JJ derivative_NN of_IN the_DT amino-terminal_JJ truncation_NN of_IN Ypk1_NP upon_IN galactose_NN induction_NN ._SENT Protein_NN Localization_NN by_IN Using_VBG Chimeras_NP Containing_NP Green_NP Fluorescent_NP Protein_NP (_( GFP_NP )_) |_SYM To_TO create_VB vectors_NNS for_IN galactose-inducible_JJ expression_NN of_IN YPK1_NP ,_, YKR2_NP ,_, and_CC PKH2_NP ,_, each_DT fused_VBN to_TO the_DT carboxy_JJ terminus_NN of_IN a_DT protein_NN comprising_VBG three_CD tandem_JJ repeats_NNS of_IN an_DT enhanced_JJ (_( S65T_NP V163A_NP )_) mutant_NN of_IN GFP_NP ,_, the_DT following_VBG approach_NN was_VBD taken_VBN ._SENT Two_CD primers_NNS ,_, 5'-GCG_NP AGC_NP GGG_NP ATC_NP CAT_NP G_NP ,_, the_DT first_JJ 18_CD bases_NNS of_IN the_DT gene-3_NN '_POS (_( primer_NN A_NP )_) ,_, where_WRB underlined_VBD bases_NNS correspond_VB to_TO an_DT introduced_VBN BamHI_NP site_NN and_CC start_NN codon_NN in_IN bold_JJ ;_: and_CC 5'-GGC_NP ACG_NP CGT_NP CGA_NP CTT_NP A_NP ,_, the_DT last_JJ 18_CD bases_NNS of_IN the_DT gene-3_NN '_POS (_( primer_NN B_NP )_) ,_, where_WRB underlined_VBD bases_NNS correspond_VB to_TO an_DT introduced_VBN SalI_NP site_NN and_CC stop_VB codon_NN in_IN bold_JJ ,_, were_VBD used_VBN to_TO amplify_VB the_DT entire_JJ open_JJ reading_NN frames_NNS of_IN the_DT corresponding_JJ genes_NNS from_IN genomic_JJ DNA_NN ._SENT The_DT PCR_NP products_NNS were_VBD digested_VBN with_IN BamHI_NP and_CC SalI_NP and_CC ligated_VBN into_IN vector_NN pGS836_NN (_( YCpGAL-3GFP_NP )_) that_WDT had_VBD been_VBN digested_VBN with_IN BamHI_NP and_CC SalI_NP ,_, yielding_VBG plasmids_NNS pGAL-3GFP-YPK1_JJ (_( pFR33_NN )_) ,_, pGAL-3GFP-YKR2_JJ (_( pER2_JJ )_) ,_, and_CC pGAL-3GFP-PKH2_JJ (_( pER3_NN )_) ._SENT To_TO create_VB pGAL-3GFP-PKH1_JJ (_( pFR37_JJ )_) ,_, the_DT same_JJ approach_NN was_VBD used_VBN ,_, but_CC due_JJ to_TO the_DT presence_NN of_IN BamHI_NP and_CC SalI_NP restriction_NN sites_NNS in_IN the_DT gene_NN ,_, two_CD PCR_NP products_NNS were_VBD made_VBN ,_, one_CD with_IN primer_NN A_DT and_CC a_DT primer_NN corresponding_JJ to_TO the_DT sequence_NN 3_CD '_'' to_TO the_DT ClaI_NP site_NN present_NN in_IN PKH1_NP ,_, and_CC the_DT other_JJ with_IN a_DT primer_NN 3_CD '_'' of_IN the_DT ClaI_NP site_NN and_CC primer_NN B._NP A_DT three-way_JJ ligation_NN was_VBD then_RB used_VBN to_TO ligate_VB the_DT two_CD PCR_NP products_NNS digested_VBN with_IN BamHI_NP and_CC ClaI_NP ,_, or_CC ClaI_NP and_CC SalI_NP ,_, into_IN pGS836_NN that_WDT had_VBD been_VBN digested_VBN with_IN BamHI_NP and_CC SalI_NP ._SENT Cells_NNS expressing_VBG the_DT GFP_NP constructs_NNS were_VBD grown_VBN to_TO mid-exponential_JJ phase_NN at_IN 30C_JJ in_IN SC-Leu_NP containing_VBG Raf/Suc_NP and_CC then_RB induced_VBN with_IN 2_CD %_NN galactose_NN for_IN 3_CD h._NP Nuclear_NP DNA_NP was_VBD stained_VBN with_IN 4,6-diamidino-2-phenylindole_JJ (_( DAPI_NP )_) by_IN adding_VBG the_DT dye_NN directly_RB in_IN the_DT medium_NN at_IN a_DT concentration_NN of_IN 1_CD mug/ml_NN for_IN the_DT last_JJ hour_NN of_IN growth_NN ._SENT Rhodamine-labeled_JJ phalloidin_NN was_VBD purchased_VBN from_IN Molecular_NP Probes_NP (_( Eugene_NP ,_, OR_NP )_) ._SENT Samples_NNS of_IN each_DT culture_NN were_VBD viewed_VBN directly_RB with_IN a_DT TE300_NP fluorescence_NN microscope_NN (_( Nikon_NP ,_, Melville_NP ,_, NY_NP )_) equipped_VBD with_IN a_DT 100x/1.4_JJ Plan-Apo_NP objective_NN and_CC a_DT 1.4_CD numerical_JJ aperture_NN condenser_NN ._SENT Digital_NP images_NNS were_VBD acquired_VBN with_IN a_DT bottom-ported_JJ Orca_NP 100_CD charge-coupled_JJ device_NN camera_NN (_( Hamamatsu_NP ,_, Bridgewater_NP ,_, NJ_NP )_) and_CC Phase_NP 3_CD Imaging_NP Systems_NP software_NN (_( Northern_NP Exposure_NP ,_, Inc._NP ,_, Glen_NP Mills_NP ,_, PA_NP )_) ._SENT The_DT fraction_NN of_IN lysed_VBN cells_NNS in_IN cultures_NNS was_VBD assessed_VBN by_IN direct_JJ counting_NN of_IN at_IN least_JJS 200_CD cells_NNS after_IN staining_VBG with_IN a_DT vital_JJ dye_NN (_( LIVE/DEAD_NP Yeast_NP Viability_NP kit_NN ;_: catalog_NN no_RB ._SENT 7009_LS ;_: Molecular_JJ Probes_NNS )_) ._SENT Antibody_NN Production_NN |_SYM To_TO express_VB a_DT glutathione_NN S-transferase_NN (GST)-Ypk1_JJ fusion_NN protein_NN in_IN E._NP coli_NNS ,_, an_DT similar370-base_JJ pair_NN fragment_NN corresponding_JJ to_TO the_DT first_JJ 114_CD amino_NN acids_NNS of_IN Ypk1_NP was_VBD amplified_VBN by_IN PCR_NP from_IN pYPK1_NN by_IN using_VBG the_DT following_VBG oligonucleotides_NNS :_: 5'-GGG_NP GGG_NP GGA_NP TCCATG_NP TAT_NP TCT_NP TGG_NP AAG_NP TCA_NP AAG_NP TTT-3_NP '_POS ,_, where_WRB the_DT underlined_VBN nucleotides_NNS correspond_VBP to_TO an_DT introduced_VBN BamHI_NP site_NN ,_, and_CC the_DT bold_JJ nucleotides_NNS correspond_VBP to_TO the_DT start_NN codon_NN ;_: and_CC 5'-GGG_NP GGG_NP AAT_NP TCT_NP CAG_NP GTG_NP GCA_NP TCA_NP TTG_NP GGT_NP GTC_NP CC-3_NP '_POS ,_, where_WRB the_DT underlined_VBN nucleotides_NNS correspond_VBP to_TO an_DT introduced_VBN EcoRI_NP site_NN ,_, and_CC the_DT bold_JJ nucleotides_NNS correspond_VBP to_TO the_DT reverse_JJ complement_NN of_IN an_DT introduced_VBN stop_NN codon_NN ._SENT This_DT PCR_NP fragment_NN was_VBD then_RB digested_VBN with_IN BamHI_NP and_CC EcoRI_NP ,_, gel_NN purified_VBD ,_, and_CC ligated_VBD into_IN the_DT pGEX2T_NN vector_NN (_( Pharmacia_NP ,_, Peapack_NP ,_, NJ_NP )_) ,_, which_WDT had_VBD been_VBN linearized_VBN with_IN BamHI_NP and_CC EcoRI_NP to_TO create_VB plasmid_NP pGEX-Ypk1_NP (_( pAM5_NN )_) ._SENT To_TO express_VB a_DT GST-Ykr2_NP fusion_NN protein_NN in_IN E._NP coli_NNS ,_, an_DT similar360-base_JJ pair_NN fragment_NN corresponding_JJ to_TO the_DT first_JJ 111_CD amino_NN acids_NNS of_IN Ykr2_NP was_VBD amplified_VBN by_IN PCR_NP from_IN pYKR2_NN by_IN using_VBG the_DT following_VBG olignucleotides_NNS :_: 5'-GGG_NP GGG_NP GGA_NP TCCATG_NP CAT_NP TCC_NP TGG_NP CGA_NP ATA_NP TCC_NP AAG-3_NP '_POS ,_, where_WRB the_DT underlined_VBN nucleotides_NNS correspond_VBP to_TO an_DT introduced_VBN BamHI_NP site_NN ,_, and_CC the_DT bold_JJ nucleotides_NNS correspond_VBP to_TO the_DT start_NN codon_NN ;_: and_CC 5'-GGG_NP GGG_NP AAT_NP TCT_NP CAA_NP CTC_NP GGT_NP CCC_NP TGC_NP GTC_NP TCA_NP GT-3_NP '_POS ,_, where_WRB the_DT underlined_VBN nucleotides_NNS correspond_VBP to_TO an_DT introduced_VBN EcoRI_NP site_NN ,_, and_CC the_DT bold_JJ nucleotides_NNS correspond_VBP to_TO the_DT reverse_JJ complement_NN of_IN an_DT introduced_VBN stop_NN codon_NN ._SENT This_DT PCR_NP fragment_NN was_VBD then_RB digested_VBN with_IN BamHI_NP and_CC EcoRI_NP ,_, gel_NN purified_VBD ,_, and_CC ligated_VBD into_IN the_DT pGEX2T_JJ vector_NN ,_, which_WDT had_VBD been_VBN linearized_VBN with_IN BamHI_NP and_CC EcoRI_NP to_TO create_VB plasmid_NP pGEX-Ykr2_NP (_( pAM6_NN )_) ._SENT To_TO prepare_VB antigen_NN ,_, expression_NN of_IN GST-Ypk1(1-114)_NP and_CC GST-Ykr2(1-111)_NP fusions_NNS from_IN plasmids_NNS ,_, pGEX-Ypk1_JJ and_CC pGEX-Ykr2_JJ ,_, respectively_RB ,_, were_VBD induced_VBN in_IN a_DT protease-deficient_JJ E._NP coli_NNS strain_VBP BL21_JJ (DE3)[pLys_NNS ]_SYM by_IN addition_NN of_IN isopropyl-beta-d-thiogalacto-pyranoside_NN to_TO a_DT final_JJ concentration_NN of_IN 0.2_CD mM_NNS followed_VBN by_IN incubation_NN with_IN aeration_NN for_IN 2_CD h_NN at_IN 30C_JJ ._SENT Cells_NNS were_VBD harvested_VBN ,_, washed_VBN once_RB with_IN ice-cold_JJ wash_NN buffer_NN (_( 50_CD mM_NP Tris-HCl_NP pH_NN 8_CD ,_, 0.5_CD mM_JJ dithiothreitol_NN [_SYM DTT_NP ]_SYM ,_, 100_CD mM_NP KCl_NP ,_, 1_CD mM_NP phenylmethylsulfonyl_NN fluoride_NN ,_, 0.05_CD %_NN NP-40_NP ,_, 1_CD mM_NP EGTA_NP ,_, and_CC 1_CD mM_NP EDTA_NP )_) ,_, and_CC resuspended_VBD in_IN 1/20_CD volume_NN of_IN wash_NN buffer_NN containing_VBG 1_CD M_NP NaCl_NP ._SENT Cells_NNS were_VBD disrupted_VBN by_IN digestion_NN with_IN lysozyme_NN (_( final_JJ concentration_NN ,_, 2_CD mg/ml_NN )_) followed_VBN by_IN sonication_NN ._SENT Insoluble_JJ material_NN was_VBD removed_VBN by_IN centrifugation_NN at_IN 12,000_CD x_NN g_NN ,_, and_CC the_DT soluble_JJ GST-Ypk1(1-114)_NP or_CC GST-Ykr2(1-111)_NP proteins_NNS were_VBD purified_VBN by_IN adsorption_NN to_TO ,_, and_CC elution_NN from_IN ,_, glutathione-agarose_JJ beads_NNS (_( Pharmacia_NP )_) ,_, essentially_RB as_RB directed_VBN by_IN the_DT manufacturer_NN ,_, except_IN that_DT elution_NN was_VBD performed_VBN in_IN the_DT presence_NN of_IN 1_CD M_NP NaCl_NP and_CC 20_CD mM_NP glutathione_NN ._SENT The_DT purified_VBN proteins_NNS were_VBD used_VBN as_IN immunogens_NNS to_TO raise_VB polyclonal_JJ antisera_NN in_IN adult_NN female_JJ New_NP Zealand_NP White_NP rabbits_VBZ following_VBG standard_JJ immunization_NN protocols_NNS ._SENT The_DT resulting_VBG anti-Ypk1_JJ antibodies_NNS (_( serum_NN #1446_NN )_) and_CC anti-Ykr2_JJ antibodies_NNS (_( serum_NN #1732_NN )_) are_VBP specific_JJ to_TO Ypk1_NP and_CC Ykr2_NP and_CC do_VBP not_RB display_VB any_DT cross-reaction_NN against_IN the_DT incorrect_JJ antigen_NN ._SENT Anti-GFP_JJ antibodies_NNS were_VBD the_DT generous_JJ gift_NN of_IN Roger_NP Tsien_NP and_CC Charles_NP Zuker_NP (_( Department_NP of_IN Cellular_NP and_CC Molecular_NP Medicine_NP ,_, University_NP of_IN California_NP ,_, San_NP Diego_NP ,_, CA_NP )_) ._SENT Preparation_NN of_IN Cell_NP Extracts_NP and_CC Immunoblot_NP Analysis_NP |_SYM Yeast_NP cells_NNS were_VBD grown_VBN at_IN 30C_JJ to_TO mid-exponential_JJ phase_NN (_( A600_NP nm_NP =_SYM 0.5_CD --_: 1_LS )_) ,_, either_CC in_IN SC_NP medium_NN supplemented_VBN in_IN a_DT manner_NN appropriate_JJ for_IN maintenance_NN of_IN plasmids_NNS or_CC in_IN rich_JJ medium_NN (_( YPGlc_NP )_) ._SENT If_IN cells_NNS required_VBN galactose_NN induction_NN for_IN expression_NN from_IN the_DT GAL1_NP promoter_NN ,_, galactose_NN was_VBD added_VBN to_TO a_DT final_JJ concentration_NN of_IN 2_CD %_NN and_CC the_DT cultures_NNS were_VBD incubated_VBN at_IN 30C_JJ for_IN an_DT additional_JJ 2_CD h._NP Cells_NP were_VBD harvested_VBN by_IN brief_JJ centrifugation_NN ,_, washed_VBN twice_RB by_IN resuspension_NN and_CC resedimentation_NN in_IN ice-cold_JJ lysis_NN buffer_NN (_( 50_CD mM_NP Tris-HCl_NP pH_NN 7.5_CD ,_, 5_CD mM_NP EDTA_NP ,_, 3_CD mM_NP DTT_NP and_CC 1_CD mM_NP phenylmethylsulfonyl_NN fluoride_NN )_) ,_, and_CC resuspended_VBD in_IN 200_CD mul_NN of_IN the_DT same_JJ buffer_NN ._SENT Prechilled_JJ glass_NN beads_NNS (_( 0.45_CD --_: 0.6_CD mm_NN in_IN diameter_NN )_) were_VBD added_VBN to_TO the_DT meniscus_NN of_IN the_DT cell_NN suspension_NN ,_, and_CC lysis_NN was_VBD achieved_VBN by_IN vigorous_JJ vortex_NN mixing_VBG for_IN six_CD 1-min_JJ intervals_NNS ,_, with_IN intermittent_JJ cooling_NN on_IN ice_NN ._SENT To_TO remove_VB the_DT glass_NN beads_NNS ,_, the_DT bottom_NN of_IN the_DT Eppendorf_NP tube_NN was_VBD punctured_VBN with_IN a_DT syringe_NN needle_NN (_( <0.5_JJ mm_NN in_IN diameter_NN )_) and_CC inserted_VBN into_IN another_DT tube_NN ;_: the_DT lysate_NN was_VBD collected_VBN into_IN the_DT fresh_JJ tube_NN by_IN brief_JJ centrifugation_NN in_IN a_DT clinical_JJ centrifuge_NN ._SENT The_DT crude_JJ extract_NN was_VBD subjected_VBN to_TO centrifugation_NN at_IN 30,000_CD x_NN g_NN for_IN 15_CD min_NN to_TO remove_VB unbroken_JJ cells_NNS and_CC large_JJ debris_NN ._SENT The_DT protein_NN concentration_NN of_IN the_DT crude_JJ extract_NN was_VBD measured_VBN using_VBG a_DT dye-binding_JJ method_NN with_IN a_DT protein_NN assay_NN kit_NN as_IN instructed_VBN by_IN the_DT manufacturer_NN (_( ,_, Hercules_NP ,_, CA_NP )_) ,_, by_IN using_VBG bovine_JJ serum_NN albumin_NN (_( ,_, Beverly_NP ,_, MA_NP )_) as_IN the_DT standard_NN ._SENT For_IN immunoblot_NN analysis_NN ,_, samples_NNS (_( 50_CD mug_NN of_IN total_JJ protein_NN )_) were_VBD diluted_VBN into_IN SDS-PAGE_NP sample_NN buffer_NN ,_, subjected_VBN to_TO electrophoresis_NN in_IN an_DT 8_CD --_: 12_CD %_NN gel_NN ,_, and_CC then_RB transferred_VBN to_TO nitrocellulose_NN ._SENT To_TO detect_VB Ypk1_NP ,_, rabbit_NN polyclonal_JJ anti-Ypk1_JJ antiserum_NN #1446_NN was_VBD used_VBN at_IN a_DT dilution_NN of_IN 1:3000_CD ._SENT To_TO detect_VB Ykr2_NP ,_, rabbit_NN polyclonal_JJ anti-Ykr2_JJ antiserum_NN #1732_NN was_VBD used_VBN at_IN a_DT dilution_NN of_IN 1:3000_CD ._SENT To_TO detect_VB proteins_NNS using_VBG the_DT anti-c-Myc_NN monoclonal_NN antibody_NN (_( mAb_NN )_) 9E10_NN ,_, ascites_NN fluid_NN containing_VBG this_DT mAb_NN was_VBD used_VBN at_IN a_DT dilution_NN of_IN 1:10,000_CD ._SENT Immobilized_VBN immune_JJ complexes_NNS were_VBD detected_VBN using_VBG a_DT commercial_JJ chemiluminescence_NN detection_NN system_NN (_( Renaissance_NP ;_: PerkinElmer_NP Life_NP Sciences_NPS ,_, Boston_NP ,_, MA_NP )_) and_CC x-ray_NN film_NN (_( Biomax_NP MR_NP ;_: Eastman_NP Kodak_NP ,_, Rochester_NP ,_, NY_NP )_) ._SENT Immunoprecipitations_NNS |_SYM Yeast_NP cultures_NNS to_TO be_VB used_VBN for_IN immunoprecipitation_NN analysis_NN were_VBD grown_VBN as_IN described_VBN above_IN ,_, and_CC then_RB rinsed_VBN in_IN ice-cold_JJ IP_NP buffer_NN (_( 20_CD mM_NP Tris-HCl_NP pH_NN 7.5_CD ,_, 125_CD mM_NP potassium_NN acetate_NN ,_, 0.5_CD mM_NP EDTA_NP ,_, 0.5_CD mM_NP EGTA_NP ,_, 1_CD mM_NP DTT_NP ,_, 1_CD mug/ml_NN leupeptin_NN ,_, 1_CD mug/ml_NN pepstatin_NN A_NP ,_, 0.1_CD %_NN Triton_NP X-100_NP ,_, and_CC 12.5_CD %_NN glycerol_NN )_) ._SENT Glass_NN beads_NNS were_VBD added_VBN to_TO the_DT meniscus_NN of_IN the_DT cell_NN suspension_NN ,_, and_CC lysis_NN was_VBD achieved_VBN by_IN vigorous_JJ vortex_NN mixing_VBG for_IN eight_CD 30-s_JJ intervals_NNS with_IN intermittent_JJ cooling_NN on_IN ice_NN ._SENT The_DT lysate_NN was_VBD clarified_VBN by_IN centrifugation_NN at_IN 14,000_CD x_NN g_NN at_IN 4C_JJ for_IN 30_CD min_NN ._SENT The_DT clarified_VBN extract_NN was_VBD assayed_VBN for_IN protein_NN concentration_NN ,_, and_CC a_DT sample_NN (_( 1_CD mg_NN of_IN total_JJ protein_NN )_) was_VBD diluted_VBN to_TO a_DT final_JJ volume_NN of_IN 200_CD mul_NN in_IN IP_NP buffer_NN ._SENT An_DT aliquot_JJ (_( 20_CD mul_NN )_) of_IN protein_NN G/protein_NP A-agarose_NP beads_NNS (_( 30_CD %_NN slurry_NN )_) (_( Oncogene_NN Science_NN ,_, Cambridge_NP ,_, MA_NP )_) and_CC a_DT sample_NN of_IN an_DT appropriate_JJ control_NN antibody_NN ,_, either_CC 2_CD mul_NN of_IN preimmune_JJ rabbit_NN serum_NN or_CC 1_CD mug_NN of_IN purified_VBN mouse_NN anti-T-cell_NN receptor_NN antibody_NN (_( gift_NN of_IN James_NP Allison_NP ,_, Department_NP of_IN Molecular_NP and_CC Cell_NP Biology_NP ,_, University_NP of_IN California_NP ,_, Berkeley_NP ,_, CA_NP )_) ,_, were_VBD added_VBN ._SENT The_DT samples_NNS were_VBD then_RB incubated_VBN on_IN a_DT roller_NN drum_NN for_IN 1_CD h_NN at_IN 4C_JJ to_TO adsorb_VB proteins_NNS that_IN bound_VBN nonspecifically_RB to_TO the_DT solid_JJ support_NN and_CC to_TO rabbit_NN or_CC mouse_NN IgG_NP (_( preclearing_NN )_) ._SENT The_DT beads_NNS were_VBD removed_VBN by_IN centrifugation_NN for_IN 10_CD min_NN in_IN a_DT microfuge_NN ,_, and_CC the_DT supernatant_JJ fraction_NN was_VBD transferred_VBN to_TO a_DT fresh_JJ tube_NN containing_VBG another_DT aliquot_JJ (_( 15_CD mul_NN )_) of_IN protein_NN G/protein_NP A-agarose_NP beads_NNS and_CC either_RB 2_CD mul_NN of_IN anti-Ypk1_NN (_( or_CC anti-Ykr2_JJ )_) polyclonal_JJ antiserum_NN or_CC 1_CD mul_NN of_IN anti-c-Myc_NP (_( mAb_NN 9E10_NN )_) ascites_NN ,_, and_CC incubated_VBD on_IN a_DT roller_NN drum_NN for_IN 1_CD to_TO 3_CD h_NN at_IN 4C_JJ ._SENT The_DT beads_NNS were_VBD sedimented_VBN by_IN brief_JJ centrifugation_NN in_IN a_DT microfuge_NN and_CC washed_VBD three_CD times_NNS (_( 1_CD ml_NN each_DT )_) with_IN ice-cold_JJ IP_NP buffer_NN and_CC collected_VBN by_IN centrifugation_NN for_IN 1_CD min_NN in_IN a_DT microfuge_NN on_IN maximum_JJ speed_NN ._SENT Bead-bound_JJ immune_JJ complexes_NNS were_VBD solubilized_VBN in_IN SDS-PAGE_NP sample_NN buffer_NN and_CC immediately_RB boiled_VBD for_IN 5_CD min_NN in_IN a_DT water_NN bath_NN and_CC then_RB clarified_VBN by_IN brief_JJ centrifugation_NN in_IN a_DT Microfuge_NN before_IN resolution_NN by_IN SDS-PAGE_NP ._SENT The_DT proteins_NNS of_IN interest_NN were_VBD visualized_VBN as_IN described_VBN above_IN ._SENT Immune-Complex_NP Protein_NP Kinase_NP Assays_NPS |_SYM Cells_NP expressing_VBG either_DT wild-type_NN or_CC kinase-dead_NN Ypk1-myc_NP (_( or_CC Ykr2-myc_NP )_) under_IN control_NN of_IN the_DT GAL1_NP promoter_NN were_VBD grown_VBN in_IN SC_NP containing_VBG Raf/Suc_NP to_TO an_DT A600_JJ nm_NN =_SYM 0.6_CD ,_, induced_VBN by_IN addition_NN of_IN galactose_NN (_( 2_CD %_NN final_JJ concentration_NN )_) ,_, incubated_VBN with_IN shaking_VBG at_IN 30C_JJ for_IN 2_CD h_NN ,_, collected_VBN by_IN centrifugation_NN ,_, washed_VBN with_IN ice-cold_JJ 1x_NP phosphate-buffered_JJ saline_NN ,_, resuspended_VBN in_IN 0.2_CD ml_NN of_IN ice-cold_JJ IP_NP buffer_NN ,_, and_CC lysed_VBD as_RB described_VBN above_IN ._SENT The_DT resulting_VBG lysates_NNS were_VBD clarified_VBN by_IN centrifugation_NN at_IN 4C_JJ for_IN 30_CD min_NN at_IN 30,000_CD x_SYM g._FW Protein_NP concentration_NN in_IN the_DT resulting_VBG crude_NN extracts_VBZ was_VBD determined_VBN by_IN the_DT method_NN ._SENT A_DT volume_NN of_IN extract_NN containing_VBG 1_CD mg_NN of_IN total_JJ protein_NN was_VBD immunoprecipitated_VBN with_IN mAb_NN 9E10_NN as_RB described_VBD above_IN ._SENT The_DT immunoprecipitates_NNS were_VBD washed_VBN once_RB with_IN ice-cold_JJ IP_NP buffer_NN ,_, once_RB with_IN ice-cold_JJ IP_NP buffer_NN containing_VBG 0.5_CD M_NP NaCl_NP ,_, and_CC twice_RB with_IN ice-cold_JJ buffer_NN A_NP (_( 50_CD mM_NP Tris-HCl_NP pH_NN 7.5_CD ,_, 0.1_CD mM_NP EGTA_NP ,_, and_CC 0.1_CD %_NN [_SYM by_IN vol_NP ]_SYM 2-mercaptoethanol_JJ )_) ._SENT As_IN part_NN of_IN the_DT final_JJ wash_NN ,_, the_DT slurry_NN of_IN beads_NNS was_VBD split_VBN into_IN two_CD equal_JJ portions_NNS ._SENT For_IN immunoblot_NN analysis_NN ,_, SDS-PAGE_NP sample_NN buffer_NN (_( similar15_JJ mul_NN )_) was_VBD added_VBN directly_RB to_TO one_CD sample_NN of_IN each_DT bead_NN suspension_NN ._SENT For_IN protein_NN kinase_NN assays_NNS ,_, the_DT activity_NN of_IN the_DT Ypk1-myc_NP or_CC Ykr2-myc_NP immune_JJ complex_NN was_VBD assayed_VBN by_IN adding_VBG 30_CD mul_NN of_IN a_DT mixture_NN containing_VBG 1_CD muM_NN microcystin-LR_NN ,_, 10_CD mM_NP Mg-acetate_NP ,_, 100_CD muM_NN [_SYM gamma-32P]ATP_NN (_( 200_CD --_: 400_CD cpm/pmol_NN )_) ,_, and_CC 100_CD muM_NN Cross-tide_NP (_( GRPRTSSFAEG_NP )_) ,_, which_WDT we_PP have_VBP documented_VBN previously_RB is_VBZ an_DT excellent_JJ peptide_NN phospho-acceptor_NN substrate_NN for_IN Ypk1_NP and_CC Ykr2_NP ._SENT After_IN incubation_NN for_IN 15_CD min_NN at_IN 30C_NP ,_, each_DT reaction_NN was_VBD terminated_VBN by_IN spotting_VBG a_DT portion_NN (_( 45_CD mul_NN )_) of_IN the_DT reaction_NN mixture_NN onto_IN small_JJ squares_NNS of_IN phosphocellulose_JJ paper_NN (_( P81_NP ;_: Whatman_NP ,_, Maidstone_NP ,_, United_NP Kingdom_NP )_) ,_, which_WDT were_VBD washed_VBN and_CC analyzed_VBN as_IN described_VBN in_IN detail_NN previously_RB ._SENT In_IN some_DT experiments_NNS ,_, samples_NNS of_IN the_DT immunoprecipitates_NNS were_VBD resuspended_VBN in_IN an_DT appropriate_JJ buffer_NN (_( 20_CD mM_NP Tris-HCl_NP pH_NN 8.8_CD and_CC 10_CD mM_NP MgCl2_NP )_) and_CC treated_VBN with_IN shrimp_NN alkaline_JJ phosphatase_NN (_( 0.25_CD U_NP ;_: US_NP Biochemical_NP ,_, Cleveland_NP ,_, OH_NP )_) in_IN either_CC the_DT absence_NN or_CC presence_NN of_IN a_DT mixture_NN of_IN inhibitors_NNS of_IN this_DT phosphatase_NN (_( 25_CD muM_NN Na-orthovanadate_NN and_CC 100_CD muM_NN beta-glycerol-phosphate_NN ,_, adjusted_VBN to_TO pH_NN 8_CD )_) ._SENT Bioassays_NNS for_IN Drug_NP Sensitivity_NP |_SYM An_DT agar_NN diffusion_NN (_( halo_NN )_) assay_NN was_VBD performed_VBN to_TO test_VB the_DT relative_JJ sensitivity_NN of_IN various_JJ strains_NNS to_TO rapamycin_NN ,_, valinomycin_NP ,_, hygromycin_NP B_NP ,_, cycloheximide_NN ,_, and_CC polyoxin_NP D._NP Nascent_JJ lawns_NNS of_IN the_DT strains_NNS to_TO be_VB tested_VBN were_VBD prepared_VBN by_IN mixing_VBG similar2_NNS x_SYM 106_CD cells_NNS from_IN a_DT saturated_JJ culture_NN with_IN 2_CD ml_NN of_IN molten_JJ (_( 55C_NN )_) 1_CD %_NN agar_NN ._SENT The_DT cell-containing_NN agar_NN was_VBD rapidly_RB mixed_VBN and_CC immediately_RB poured_VBD evenly_RB onto_IN plates_NNS containing_VBG an_DT appropriate_JJ medium_NN ._SENT Various_JJ concentrations_NNS of_IN rapamycin_NN (_( 50_CD and_CC 500_CD ng/mul_NNS )_) ,_, hygromycin_NP B_NP (_( 5_CD and_CC 50_CD mug/mul_NN )_) ,_, or_CC the_DT other_JJ drugs_NNS indicated_VBD ,_, were_VBD spotted_VBN in_IN the_DT same_JJ volume_NN (_( 10_CD mul_NN )_) onto_IN sterile_JJ cellulose_NN filter_NN discs_NNS (_( 0.6_CD cm_NN )_) ,_, which_WDT were_VBD placed_VBN on_IN the_DT nascent_JJ lawn_NN ._SENT The_DT plates_NNS were_VBD incubated_VBN at_IN 30C_JJ ,_, and_CC photographed_VBN after_IN 2_CD d._NP Selection_NP and_CC Analysis_NP of_IN Dosage_NP Suppressors_NP |_SYM A_DT library_NN of_IN restriction_NN fragments_NNS of_IN yeast_NN genomic_JJ DNA_NN cloned_VBN into_IN a_DT URA3-marked_JJ ,_, 2-mum_JJ DNA-based_JJ vector_NN ,_, YEp352_NP ,_, was_VBD introduced_VBN into_IN strain_NN YPT40_NP (_( ypk1-1ts_NP ykr2Delta_NP )_) by_IN selecting_VBG transformants_NNS on_IN SCGlc-Ura_NP medium_NN at_IN 26C_JJ ._SENT Temperature-resistant_JJ clones_NNS were_VBD then_RB selected_VBN by_IN their_PP$ ability_NN to_TO grow_VB at_IN 35C_JJ ._SENT One_CD suppressor_NN plasmid_NN obtained_VBN carried_VBD the_DT EXG1_JJ locus_NN as_IN the_DT sole_JJ open_JJ reading_NN frame_NN ._SENT To_TO create_VB a_DT plasmid_NN that_WDT expressed_VBD EXG1_JJ from_IN a_DT high-level_JJ constitutive_JJ promoter_NN ,_, two_CD primers_NNS ,_, 5'-GCG_NP TCT_NP CGA_NP GAT_NP GCT_NP TTC_NP GCT_NP TAA_NP AA-3_NP '_POS ,_, where_WRB the_DT underlined_VBN bases_NNS correspond_VBP to_TO an_DT introduced_VBN XhoI_NP site_NN ,_, and_CC the_DT start_NN codon_NN is_VBZ in_IN bold_JJ ;_: and_CC 5'-CGC_NP CGG_NP AGC_NP TC_NP T_NN TAG_NP TTA_NP GAA_NP ATT_NP GTG_NP CC-3_NP '_POS ,_, where_WRB the_DT underlined_VBN bases_NNS correspond_VBP to_TO an_DT introduced_VBN SacI_NP site_NN ,_, and_CC the_DT stop_NN codon_NN is_VBZ in_IN bold_JJ ,_, were_VBD used_VBN to_TO amplify_VB the_DT entire_JJ open_JJ reading_NN frame_NN of_IN EXG1_NP from_IN the_DT library_NN plasmid_NN that_WDT was_VBD originally_RB isolated_VBN as_IN a_DT dosage_NN suppressor_NN of_IN the_DT ypk1-1ts_NNS ykr2Delta_NN strain_NN (_( see_VB RESULTS_NP )_) ._SENT This_DT 1.4-kb_JJ PCR_NP product_NN was_VBD digested_VBN with_IN XhoI_NP and_CC SacI_NP and_CC ligated_VBN into_IN vector_NN pAD4_NN M_NN that_WDT had_VBD been_VBN digested_VBN with_IN SalI_NP and_CC SacI_NP ,_, yielding_VBG pADH-EXG1_JJ (_( pAM88_NN )_) ._SENT To_TO express_VB PKC1_JJ from_IN its_PP$ own_JJ promoter_NN on_IN a_DT high_JJ copy_NN number_NN (_( 2-mum_JJ DNA_NN )_) plasmid_NP ,_, a_DT 4.2-kb_JJ NsiI_NP fragment_NN containing_VBG the_DT entire_JJ open_JJ reading_NN frame_NN of_IN PKC1_NP as_RB well_RB as_IN 560_CD base_NN pairs_NNS upstream_RB of_IN the_DT ATG_NP and_CC 175_CD base_NN pairs_NNS downstream_JJ of_IN the_DT stop_NN codon_NN ,_, was_VBD cut_VBN out_RP of_IN a_DT genomic_JJ clone_NN obtained_VBN by_IN F._NP Owen_NP Fields_NPS (_( this_DT laboratory_NN ;_: ;_: )_) and_CC ligated_VBN into_IN the_DT URA3-based_JJ plasmid_NP YEp352_NP that_WDT had_VBD been_VBN linearized_VBN with_IN PstI_NP ,_, yielding_VBG plasmid_NP pPKC-PN_NP ,_, or_CC into_IN the_DT LEU2-based_JJ plasmid_NP YEp351_NP that_WDT had_VBD been_VBN linearized_VBN with_IN PstI_NP ,_, yielding_VBG plasmid_NN pFR32_NN ._SENT To_TO express_VB BCK1-20_NP in_IN a_DT 